Evidence map›Paper›PMID 28544524›Full record

ArticleImmunity, inflammation and disease2017

Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis.

Shinya Goto, Satoru Konnai, Tomohiro Okagawa, Asami Nishimori, Naoya Maekawa, Satoshi Gondaira, Hidetoshi Higuchi, Masateru Koiwa, Motoshi Tajima, Junko Kohara and 5 more

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology.Animals : an open access journal from MDPI · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Immune Evasion ofPathogens (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Outer Membrane Vesicles FromFrontiers in microbiology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Shinya GotoDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Satoru KonnaiDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-3230-7109
Tomohiro OkagawaDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Asami NishimoriDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Naoya MaekawaDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Satoshi GondairaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Hidetoshi HiguchiSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Masateru KoiwaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Motoshi TajimaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Junko KoharaHokkaido Research Organization, Agriculture Research Department, Animal Research Center, Shintoku, Japan.
Satoshi OgasawaraDepartment of Regional Innovation, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yukinari KatoDepartment of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0001-5385-8201
Yasuhiko SuzukiDivision of Bioresources, Research Center for Zoonosis, Hokkaido University, Sapporo, Japan.
Shiro MurataDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Kazuhiko OhashiDepartment of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Hokkaido University · JPRakuno Gakuen University · JPTohoku University · JPHokkaido Research Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBovine mycoplasma, chiefly Mycoplasma bovis, is a pathogen that causes pneumonia, mastitis, arthritis, and otitis media in cattle. This pathogen exerts immunosuppressive effects, such as the inhibition of interferon production. However, the mechanisms involved in bovine mycoplasmosis have not been fully elucidated. In this study, we investigated the role of the programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway in immunosuppression in bovine mycoplasmosis.

methodsIn the initial experiments, we used enzyme-linked immunosorbent assay to measure interferon-γ (IFN-γ) from peripheral blood mononuclear cells (PBMCs) isolated from cattle with mycoplasmosis.

resultsExpectedly, IFN-γ production significantly decreased in cattle with mycoplasmosis compared with that in clinically healthy cattle. Concomitantly, flow cytometric analysis revealed that the proportions of PD-1

conclusionsThese results suggest that the PD-1/PD-L1 pathway could be involved in immune exhaustion of bovine mycoplasma-specific T cells. In conclusion, our study opens up a new perspective in the therapeutic strategy for bovine mycoplasmosis by targeting the immunoinhibitory receptor pathways.

Indexed as

AnimalsB7-H1 AntigenCattleCattle DiseasesGene Expression RegulationInterferon-gammaMycoplasma bovisMycoplasma InfectionsProgrammed Cell Death 1 ReceptorT-LymphocytesB7-H1 AntigenInterferon-gammaProgrammed Cell Death 1 ReceptorBovine mycoplasmosisIFN-γimmunosuppressionPD-1PD-L1

Identifiers

PMID28544524
PMCPMC5569371
OpenAlexW2617119574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.